Bioavailability Control by Drug Delivery System DesignVictor F. Smolen, LuAnn Ball |
Contents
Physiological Factors Affecting Oral Bioavailability | 4 |
Formulation Factors Affecting Oral Bioavailability | 39 |
Therapeutic SystemsThe ALZA Concept | 65 |
Copyright | |
37 other sections not shown
Common terms and phrases
acid activity agents Albisser algorithm anesthesia aqueous humor automatic bioavailability blood glucose cardiac cells Chem Clin clinical control system controlled release cornea cyclodextrin cyclodextrin complex delivery systems developed device diabetics diffusion digoxin disease dissolution dosage form dose drug concentration drug delivery drug release effect ethylene-vinyl acetate excretion factors feedback control Figure formulation gastrointestinal heparin hepatic hormone human implantable in-vitro in-vivo increase indomethacin injection insulin infusion insulin infusion system insulin SAFCAD intestine intravenous kinetics lidocaine macromolecules membrane Metab metabolism molecular monitoring normal ocular ointment open-loop ophthalmic Ophthalmol optimal oral administration Parenteral patients penetration percutaneous absorption permeability permission from reference Pharm Pharmacokinet Pharmacol pharmacological pilocarpine plasma polymer pressure propranolol protein rabbits rats reduced regimens release rate renal Reproduced with permission response salicylic acid scopolamine serum skin solubility solution stratum corneum studies subcutaneous surface surfactants tablets therapeutic systems therapy thiopental tion tissue vehicle